Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMCSamsungVolvo
Webinar :Register now for Commodity Ki Paathshala webinar on ‘FPOs & Agriculture Marketing-The Beginning of a New Era’ on January 22, 4pm

Aurobindo Pharma gains 3% on red flags from USFDA

USFDA inspected Unit VIII, API manufacturing facility at Gaddapotharam, Hyderabad of the company.

February 26, 2020 / 10:20 AM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Aurobindo Pharma share price rose more than 3 percent in the early trade on February 26 after the company received EIR from USFDA.

The company has received the establishment inspection report (EIR) with voluntary action initiated (VAI) status from United States Food and Drug Administration (USFDA).

USFDA inspected Unit VIII, API manufacturing facility at Gaddapotharam, Hyderabad of the company.

At 09:25 hrs, Aurobindo Pharma was quoting at Rs 511.50, up Rs 7.40, or 1.47 percent on the BSE.

The share touched its 52-week high Rs 838.00 and 52-week low Rs 389.70 on 30 April, 2019 and 14 November, 2019, respectively.

Close
Currently, it is trading 39.14 percent below its 52-week high and 30.87 percent above its 52-week low.
Moneycontrol News
first published: Feb 26, 2020 10:20 am

stay updated

Get Daily News on your Browser
Sections